Ordinary people: The controlling shareholder of the pharmaceutical group intends to reduce its stake in the company by no more than 3%.

On the evening of May 6th, Lao Baixing announced that in order to adjust the asset and financing structure, decrease the stock pledge ratio, the controlling shareholder Lao Baixing Pharmaceutical Group Co., Ltd. plans to reduce its total holdings by no more than 22.8029 million shares, with a total reduction ratio not exceeding 3% of total share capital. Among them, the reduction of company shares through block trades will not exceed 15.2019 million shares, which is no more than 2% of the total share capital. The planned reduction through centralized auction trading will not exceed 7.601 million shares, which is no more than 1% of the total share capital.